(Press-News.org) Around 32 per cent of the world's population live in countries that do not adhere to the World Health Organisation’s recommendations on safe limits of arsenic in drinking water
Rice is already known to contain more inorganic arsenic than other cereals
Cooking rice with water containing more than 10 µg L-1 (parts per billion) inorganic arsenic amplifies the risk of arsenic exposure
Long-term exposure to inorganic arsenic in water can cause serious health problems such as cancers, diabetes and pulmonary and cardiovascular diseases
Rice is one of the major cereal crops in the world, contributing to the dietary energy and nutrition of more than half of the world's population
The use of water contaminated with higher than recommended levels of arsenic could pose a serious health risk to millions, a new study from the University of Sheffield has found.
New research from academics at the Institute for Sustainable Food at the University of Sheffield has found countries that do not adhere to the current World Health Organisation (WHO) recommended limits on the levels of arsenic in water are putting around 32 per cent of the global population - particularly those from low and middle-income countries - at risk of serious health issues.
Many countries worldwide still use the outdated WHO limit (50 µg L-1 or parts per billion) for inorganic arsenic in water introduced in 1963, including several Asian countries such as China, Bangladesh, Pakistan, Cambodia, Thailand, Myanmar, and Nepal, where rice is the main staple food.
Long-term exposure to arsenic in water used for drinking, food preparation or irrigation of crops can cause a range of health issues affecting every organ in the body, such as cancer, diabetes and pulmonary and cardiovascular diseases.
The new study, a first of its kind, compared how using different methods to cook common rice types with water contaminated with arsenic affected the amount absorbed into the food.
White and parboiled rice are more commonly consumed in the West and Asia, and this research found that these types accumulate more arsenic than brown rice when cooked with arsenic-spiked water. However, using arsenic-safe water removes arsenic from these rice types.
Research lead Dr Manoj Menon, from the University of Sheffield’s Institute for Sustainable Food and the Department of Geography, said: “Both rice and drinking water in the UK are regulated for arsenic, but further afield in Asia and Africa, there is often very little or no regulation to current WHO standards. We know that as many as 40 countries in the world allow more than 10 parts per billion in drinking water, and 19 countries have no evidence of any regulations.
“Rice is one of the major cereal crops in the world, contributing to the dietary energy and nutrition of more than half of the world's population. We already know that rice has more arsenic than other cereals, and the risk is exacerbated if we cook rice with arsenic-contaminated water above the WHO recommended limit.
“That is why it is vitally important that countries worldwide work to adopt the latest WHO recommendations to ensure arsenic exposure is minimised as much as possible to protect the public.”
The study tested varying levels of inorganic arsenic in the cooking water, including 10 and 50 µg L-1 and arsenic-safe tap water from the UK ( which contains less than 0.2 parts per billion) as a control.
Dr Menon said: “India has a huge population that was affected by an arsenic problem, and a few years ago it adopted 10 parts per billion as its standard, setting a good example for the other countries that are yet to adopt this.
“Obviously, for people in countries where rice is a staple food, consumption is higher and the health risk also increases, such as in many parts of Asia. People in the UK may only consume around 5kg of rice annually, but the average global consumption is 57kg, and even higher at 85kg across Asia.
“In this study, we evaluated the exposure risks to the Bangladesh population–the highest per capita rice consumers in the world at approximately 170 kg per person, and found that nearly all age groups are at significant risk. Policymakers in those countries with high rice consumption rates urgently need to develop measures to supply arsenic-safe water for domestic use.”
Previous studies by the team found that the way rice is cooked is also meaningful in reducing arsenic loading, with certain methods able to remove more than half of the naturally occurring arsenic within rice grains. So, the study tested white and brown rice against two of the most commonly used cooking methods, using excess water (EW) and parboiled and absorbed (PBA).
This new research found that if there is no access to arsenic-safe water, the best way to cook rice is using the EW method, which is drained off when done (like pasta or noodles) to reduce the risks.
Dr Menon added: “One of the United Nations (UN) Sustainable Development Goals for good health and wellbeing is for everyone to have access to clean water and sanitation. This cannot happen without regulations being implemented in countries where limits or water testing are not currently in place.
“There are genuine concerns for rice consumers about consuming arsenic, but our successive studies have shown there are ways we can try to minimise our risk of exposure. Even in countries where there may be higher levels of inorganic arsenic in water supplies, where possible, this includes selecting varieties of rice that don’t absorb as much arsenic and using cooking methods that remove as much arsenic from the water and grains as possible.”
ENDS
Notes to editors:
Publication (open access): Menon et al. 2024. A comparison of the effects of two cooking methods on arsenic species and nutrient elements in rice. Science of the Total Environment. 914. 16965. https://doi.org/10.1016/j.scitotenv.2023.169653#
IMAGES https://drive.google.com/drive/folders/1-x2w6_0r5DbNeDnV32yf_dAtF03ewyJp?usp=sharing
Media contact: Media Team, University of Sheffield, mediateam@sheffield.ac.uk, 0114 222 1050.
The University of Sheffield
The University of Sheffield is a leading Russell Group university, with a world-class reputation. Over 30,000 students from 150 countries study at Sheffield. In a truly global community, they learn alongside over 1,500 of the world’s leading academics.
Sheffield’s world-shaping research feeds into its excellent education. Students learn at the leading edge of discovery from researchers who are tackling today’s biggest global challenges.
Driven by outstanding people, staff and students share a commitment to changing the world for the better, through the power and application of ideas and knowledge.
From the first documented use of penicillin as a therapy in 1930, to building Europe’s largest research-led manufacturing cluster, Sheffield’s inventive spirit and top quality research environment sets it apart.
Current research partners include Boeing, Rolls-Royce, Unilever, AstraZeneca, GlaxoSmithKline, Siemens and Airbus, as well as many government agencies and charitable foundations.
Sheffield’s Students’ Union has won the Whatuni Student Choice Award for Best Students’ Union for six consecutive years. Students can choose from 350 societies and clubs, or join over 2,000 volunteers.
Over 300,000 Sheffield alumni from 205 different countries make a significant influence across the world, with six Nobel Prize winners included amongst former staff and students.
To find out more, visit: www.sheffield.ac.uk
END
Millions are at risk using high arsenic water for cooking
2024-03-21
ELSE PRESS RELEASES FROM THIS DATE:
TLI investigator Dr. Nicholas Jenzjowsky receives NIH/NIAID grant to investigate the neural regulation of asthma
2024-03-21
In a significant stride for respiratory medicine, Lundquist Institute (TLI) investigator Nicholas Jendzjowsky, PhD, has been awarded a prestigious grant from the National Institute of Health/National Institute of Allergy and Infectious Diseases (NIH/NIAID). This grant, totaling $298,800, not only underscores TLI's commitment to pioneering research and excellence in respiratory medicine and exercise physiology but also recognizes Dr. Jendzjowsky's expertise and the importance of his research.
The ...
Doctors’ pay in England has declined by 25% since 2008
2024-03-21
Doctors’ pay in England has declined by 25% since 2008
Independent analysis shows doctors’ salary erosion far outstrips other UK workers
Doctors describe how they struggle to afford everyday essentials
Trainee eye surgeon quit after worry over gas bill
As doctors in England enter their 13th month of industrial action, an independent analysis of their pay confirms that the real terms value of their salaries has declined by a quarter in the 15 years since their pay was frozen.
The analysis – conducted for The BMJ by the Office of Health Economics (OHE), an independent health economics research organisation – found that across ...
NIH grant funds research on work-related asthma among nurses
2024-03-21
A researcher at the University of Arizona Mel and Enid Zuckerman College of Public Health received a $750,000 National Institutes of Health grant to study the asthma risks associated with the use of cleaning and disinfecting products among nurses.
Cleaning processes in health care facilities involve an inherent “risk-risk tradeoff.” Increased use of cleaning and disinfection products leads to increased work-related asthma risks and simultaneously a decrease in occupational-infection risks.
Preliminary survey data indicate that nurses are generally willing to increase infection risks to maintain lower asthma risks if they think they will recover.
“Translating ...
AI tool predicts risk of side effects after surgery and radiotherapy in breast cancer patients
2024-03-21
Milan, Italy: A team of international researchers have developed an artificial intelligence (AI) tool that can predict which breast cancer patients may be at risk of side effects after surgery and radiotherapy.
Dr Tim Rattay told the 14th European Breast Cancer Conference (EBCC14) in Milan today (Thursday) that the tool will be tested in a clinical trial that will start recruiting in the last quarter of this year in three countries: France, The Netherlands and the UK.
“It is an explainable AI tool, which means that it shows the reasoning behind its decision-making. This makes it ...
Adding ribociclib to hormone therapy reduces the risk of breast cancer recurrence
2024-03-20
A new treatment approach that combines a targeted therapy drug with hormone therapy significantly increased the amount of time a person with stage 2 or 3 HR-positive, HER2-negative early breast cancer lives without the cancer returning, according to a new study co-led by UCLA Health Jonsson Comprehensive Cancer Center investigators.
The team found adding ribociclib, a drug that belongs to a class of CDK4/6 inhibitors, to standard hormone therapy not only improved invasive-free survival in women with this type of early-stage breast cancer, but also improves distant disease-free survival and recurrence-free survival.
The results were published today in the New England ...
Social isolation linked to biological age gap, higher mortality rate
2024-03-20
ROCHESTER, Minn. — A new study from Mayo Clinic finds that socially isolated people are more likely to show signs of being biologically older than their age and more likely to die from a variety of causes. The research, published in the Journal of the American College of Cardiology: Advances, suggests that social connection plays an important role in overall physical health and longevity, and it should be addressed as a necessary part of the social determinants of health.
To investigate the role of social contact in biological aging, the ...
New commentary: Combatting digital redlining is imperative for advancing health equity
2024-03-20
Broadband plays a critical role in most aspects of modern-day life, yet over 42 million Americans still lack access to high-speed Internet. This digital divide is driven by “digital redlining”—discriminatory disinvestment in broadband infrastructure that disproportionately affects people of color, low-income communities, and rural populations, worsening disparities in access to healthcare, social services, education, and employment for these populations.
Addressing digital redlining and the digital divide is imperative for ...
Drug-pricing program improved prostate cancer treatment adherence
2024-03-20
ANN ARBOR, Michigan — Prostate cancer patients receiving care at hospitals that are part of a special drug-pricing program were more likely to stick to their prescription drug therapy than patients at other hospitals, according to a study from researchers at the University of Michigan’s Rogel Cancer Center and Institute for Healthcare Policy and Innovation.
The 340B Drug Pricing Program is a federal program that requires the pharmaceutical industry to provide a discount on the cost of drugs to participating hospitals who serve a disproportionate number of Medicare and Medicaid patients. The program was started to enable hospitals to stretch scarce resources, ...
Prenatal exposure to antiseizure medication topiramate may not increase children’s risk of autism spectrum disorder
2024-03-20
Embargoed for release: Wednesday, March 20, 5:00 PM ET
Key points:
In a study of 4.3 million pregnant women and their children, prenatal exposure to topiramate, an antiseizure medication used to treat epilepsy, bipolar disorder, and migraines, was not associated with additional risk of the children developing autism spectrum disorder (ASD).
Consistent with previous research, the study also found that prenatal exposure to valproate and lamotrigine—two other antiseizure medications—were associated with ...
Experimental gene therapy for giant axonal neuropathy shows promise in NIH clinical trial
2024-03-20
An investigational gene therapy for a rare neurodegenerative disease that begins in early childhood, known as giant axonal neuropathy (GAN), was well tolerated and showed signs of therapeutic benefit in a clinical trial led by the National Institutes of Health (NIH). Currently, there is no treatment for GAN and the disease is usually fatal by 30 years of age. Fourteen children with GAN, ages 6 to 14 years, were treated with gene transfer therapy at the NIH Clinical Center and then followed for about six years to assess safety. Results ...